- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02127255
Acupuncture for Chemical Therapy Induced Nausea and Vomiting: a Cross-over Trail (ACTIN)
April 14, 2016 updated by: Yutong Fei, Beijing University of Chinese Medicine
This is a randomized, controlled cross-over trial.
The hypothesis of this study is that the differences in manual acupuncture manipulation can impact clinical effect though the acupuncturists follow the same needling regimen.
In this study, acupuncturist 1 (clinical experience >15 years) and acupuncturist 2 (<5 years) will give treatments to cancer patients receiving cisplatin chemotherapy (n=36) for at least two continuous cycles, once per day, 5 days per cycle.
Acupuncturist 1 determines all the treatment regimens (selection of acupoints and methods of needling manipulation, needle retention time).
Randomly, half of the patients will receive treatments from acupuncturist 1 in the first treatment cycle and from acupuncturist 2 in the second cycle; while the other half will be treated in other way round.
There is a washout period (21 days) between two cycles.
The needling manipulation of two acupuncturists will be measured objectively during treatments.
The clinical effect will be measured by the control of vomiting and nausea during and after chemotherapy treatments.
Study Overview
Status
Completed
Conditions
Detailed Description
This is a randomized, controlled cross-over trial.
The hypothesis of this study is that the differences in manual acupuncture manipulation can impact clinical effect though the acupuncturists follow the same needling regimen.
In this study, acupuncturist 1 (clinical experience >15 years) and acupuncturist 2 (<5 years) will give treatments to cancer patients receiving cisplatin chemotherapy (n=36) for at least two continuous cycles, once per day, 5 days per cycle.
Acupuncturist 1 determines all the treatment regimens (selection of acupoints and methods of needling manipulation, needle retention time).
Randomly, half of the patients will receive treatments from acupuncturist 1 in the first treatment cycle and from acupuncturist 2 in the second cycle; while the other half will be treated in other way round.
There is a washout period (21 days) between two cycles.
The needling manipulation of two acupuncturists will be measured objectively during treatments.
The clinical effect will be measured by the control of vomiting and nausea during and after chemotherapy treatments.
The manual manipulation of two acupuncturists will be recorded by device Acusensor.
Study Type
Interventional
Enrollment (Actual)
39
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beijing, China, 100091
- Xiyuan Hospital, China Academy of Chinese Medical Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Confirmed diagnosis of cancer
- Must receive cancer chemotherapy containing cisplatin
- Able to complete at least two continuous chemotherapy treatment cycles
- Karnofsky performance status grade ≥60
- Must use 5-TH receptor antagonists as an antiemetic drug in the chemotherapy duration
Exclusion Criteria:
- Concurrent neoplasms or illness that induces nausea independent of chemotherapy
- Receiving radiotherapy
- Received acupuncture treatments for other conditions less than 4 weeks before chemotherapy treatment
- Severe infection
- Severe heart, liver, kidney and brain diseases
- Unconsciousness
- Psychosis
- Language barriers
- Cardiac pacemaker
- Radiotherapy or hormone therapy during chemotherapy treatments
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: A (Acupuncturist 1)
Manual acupuncture implemented by acupuncturist 1 (clinical experience >15 years)
|
Manual acupuncture once per day.
Acupuncture treatment regimens (acupoints, needling methods, needle retention time) were decided by acupuncturist 1 according to the syndrome differentiation of patients.
Acupuncturist 1 has to have more than 15 years of acupuncture clinical practice experience.
Other Names:
|
Active Comparator: B (Acupuncturist 2)
Manual acupuncture implemented by acupuncturist 2 (clinical experience < 5 years)
|
Manual acupuncture given by acupuncturist 2 once per day.
Acupuncture treatment regimens (acupoints, needling methods, needle retention time) were decided by acupuncturist 1 according to the syndrome differentiation of patients.
Acupuncturist 2 has to have less than 5 years of acupuncture clinical practice experience.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
NCI nausea and vomiting rating scale
Time Frame: day1-8 on each study period
|
day1-8 on each study period
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Rhodes Scale
Time Frame: day1-5 on each study period
|
day1-5 on each study period
|
global assessment on effectiveness by patients (VAS)
Time Frame: day 5 on each study period
|
day 5 on each study period
|
patients' confidence towards acupuncture treatment(VAS)
Time Frame: day 1,5 on each study period
|
day 1,5 on each study period
|
global satisfaction for acupuncture treatments
Time Frame: day 5 on each study period
|
day 5 on each study period
|
Acupuncture Expectancy Scale (AES)
Time Frame: day 1, 3, 5 on each study period
|
day 1, 3, 5 on each study period
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
patient communication satisfaction scale
Time Frame: day 5 on each study period
|
day 5 on each study period
|
|
Acupuncture related adverse events
Time Frame: day 1-5 each study period
|
faintng during acupuncture treatment, sticking of needle, bleeding in the needling hole, broken needles
|
day 1-5 each study period
|
Adverse events (not acupuncture treatment specified)
Time Frame: day 1-5 each study period
|
day 1-5 each study period
|
|
Needling manipulation parameters
Time Frame: day 1-5 each study period
|
Displacement Frequency (Hz) Displacement Amplitude (pk-pk) Rotation Frequency (Hz) Rotation Amplitude (pk-pk)
|
day 1-5 each study period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yutong Fei, MD, Beijing University of Chinese Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
April 29, 2014
First Submitted That Met QC Criteria
April 29, 2014
First Posted (Estimate)
April 30, 2014
Study Record Updates
Last Update Posted (Estimate)
April 15, 2016
Last Update Submitted That Met QC Criteria
April 14, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EBM@BUCM-1
- Z111107054511086 (Other Grant/Funding Number: Beijing Nova Program)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chemotherapy-induced Nausea and Vomiting
-
GlaxoSmithKlineCompletedChemotherapy-Induced Nausea and Vomiting | Nausea and Vomiting, Chemotherapy-InducedTaiwan, United States, Germany, Russian Federation, Spain, Ireland, Thailand, Hong Kong, Mexico, Philippines, Austria, Chile, Greece, Poland, Canada, Czech Republic, United Kingdom, Hungary, Pakistan, Slovakia, Singapore, Portugal, ... and more
-
Blokhin's Russian Cancer Research CenterRUSSCO/RakFondUnknownChemotherapy-induced Nausea and Vomiting | Nausea | Vomiting | Emesis | Nausea Post ChemotherapyRussian Federation
-
Otolith LabsDrexel University College of MedicineWithdrawnChemotherapy-induced Nausea and Vomiting | Nausea Post ChemotherapyUnited States
-
Indonesia UniversityMashhad University of Medical SciencesRecruitingChemotherapy-induced Nausea and Vomiting | Chemotherapy Effect | Pediatric CancerIndonesia
-
Joseph MaTerminatedChemotherapy Induced Nausea Vomiting
-
Fudan UniversityNot yet recruitingChemotherapy-induced Nausea and Vomiting | Highly Emetogenic Chemotherapy
-
Simon Williamson ClinicHelsinn Healthcare SARecruitingChemotherapy Induced Nausea and VomitingUnited States
-
University of Illinois at ChicagoRecruitingChemotherapy-induced Nausea and VomitingUnited States
-
Antje KollerUniversity Medical Center Freiburg; ZETUP St. Gallen; Dr.-Hans-Altschüler-Sti... and other collaboratorsCompletedChemotherapy-induced Nausea and VomitingSwitzerland
-
Albert Einstein College of MedicineJacobi Medical CenterTerminatedChemotherapy-induced Nausea and VomitingUnited States
Clinical Trials on Manual acupuncture implemented by acupuncturist 1
-
Beijing University of Chinese MedicineGuang'anmen Hospital of China Academy of Chinese Medical Sciences; Xiyuan Hospital... and other collaboratorsCompletedChemotherapy-induced Nausea and VomitingChina